Pakistan recalls altered dose of Avastin; FDA rejects Botanix gel

2023-09-26

引进/卖出上市批准

Plus, MC2’s new licensing deal with Regranion and AM-Pharma announces a new CEO and workforce cuts.

Pakistan recalls altered Avastin

Pakistan is pulling a dose of Avastin from the market due to incidents of damaged vision in diabetic patients who received off-label “altered” or “diluted” versions of the injection. The Drug Regulatory Authority of Pakistan cited Genius Advanced Pharmaceutical Services, saying the issues are likely due to illegal sales of the drug under non-sterile conditions. Roche’s Avastin is approved to treat colorectal and metastatic carcinomas in Pakistan. It’s not authorized for use in diabetic patients or for other ophthalmic conditions.

Pakistan recalls altered dose of Avastin; FDA rejects Botanix gel

Preview

来源: EndPoints

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

BECOME A PREMIUM SUBSCRIBER

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构

Regranion LLC